Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as potential vision loss.

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO) popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition that can lead to vision loss, the European ...

Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged ...

Key drivers include increased prevalence, new drug approvals, and rising awareness. The report offers comprehensive analysis, segmentation by type, therapy, and region, and a vendor landscape ...

An expert reviews the data and implications of recent new drug approvals.

The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

Pain researchers have dug 100 years into the past to work toward a better future for people with diabetic neuropathy. Researchers at The University of Texas at Dallas have shown a signature ...

New research uncovers the role of forgotten cell clusters in diabetic neuropathy pain. Learn more about potential treatments and implications for pain relief.

Eli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which blocks the NaV1.8 sodium channel to treat pain. This target has ...